Build Your Comparison

Side-by-side financial analysis
TRNS logo
TRNS
SPXC logo
SPXC
JPM logo
JPM
ROP logo
ROP
BAC logo
BAC
Try popular comparisons:

Stock Comparison

TRNS vs SPXC vs JPM vs ROP vs BAC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
TRNS
Transcat, Inc.

Industrial - Distribution

IndustrialsNASDAQ • US
Market Cap$852M
5Y Perf.+252.9%
SPXC
SPX Technologies, Inc.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$11.54B
5Y Perf.+459.1%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+241.0%
ROP
Roper Technologies, Inc.

Industrial - Machinery

IndustrialsNASDAQ • US
Market Cap$34.48B
5Y Perf.-13.7%
BAC
Bank of America Corporation

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$422.78B
5Y Perf.+135.9%

TRNS vs SPXC vs JPM vs ROP vs BAC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
TRNS logoTRNS
SPXC logoSPXC
JPM logoJPM
ROP logoROP
BAC logoBAC
IndustryIndustrial - DistributionIndustrial - MachineryBanks - DiversifiedIndustrial - MachineryBanks - Diversified
Market Cap$852M$11.54B$896.00B$34.48B$422.78B
Revenue (TTM)$333M$2.35B$280.33B$8.12B$191.57B
Net Income (TTM)$7M$254M$57.05B$1.71B$30.51B
Gross Margin32.6%37.7%60.0%69.4%56.1%
Operating Margin4.1%16.9%25.9%28.1%19.7%
Forward P/E51.9x28.7x14.4x15.3x12.6x
Total Debt$129M$498M$942.38B$9.30B$365.90B
Cash & Equiv.$5M$364M$343.34B$297M$231.84B

TRNS vs SPXC vs JPM vs ROP vs BACLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

TRNS
SPXC
JPM
ROP
BAC
StockJun 20Jun 26Return
Transcat, Inc. (TRNS)100352.9+252.9%
SPX Technologies, I… (SPXC)100559.1+459.1%
JPMorgan Chase & Co. (JPM)100341.0+241.0%
Roper Technologies,… (ROP)10086.3-13.7%
Bank of America Cor… (BAC)100235.9+135.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: TRNS vs SPXC vs JPM vs ROP vs BAC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SPXC and JPM are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. JPMorgan Chase & Co. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. ROP and TRNS also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
TRNS
Transcat, Inc.
The Growth Leader

TRNS is the clearest fit if your priority is growth.

  • 19.2% revenue growth vs BAC's -0.5%
Best for: growth
SPXC
SPX Technologies, Inc.
The Growth Play

SPXC has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.

  • Rev growth 14.2%, EPS growth 17.9%, 3Y rev CAGR 15.7%
  • 14.3% 10Y total return vs TRNS's 7.7%
  • +44.9% vs ROP's -40.8%
  • 7.1% ROA vs BAC's 0.9%, ROIC 13.4% vs 3.5%
Best for: growth exposure and long-term compounding
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the #2 pick in this set and the best alternative if valuation efficiency and bank quality is your priority.

  • PEG 0.81 vs ROP's 1.59
  • NIM 2.2% vs BAC's 1.8%
  • Lower P/E (14.4x vs 15.3x), PEG 0.81 vs 1.59
  • 1.9% yield, 15-year raise streak, vs BAC's 2.3%, (2 stocks pay no dividend)
Best for: valuation efficiency and bank quality
ROP
Roper Technologies, Inc.
The Defensive Pick

ROP ranks third and is worth considering specifically for sleep-well-at-night.

  • Lower volatility, beta 0.32, Low D/E 46.8%, current ratio 0.52x
  • 21.1% margin vs TRNS's 2.0%
  • Beta 0.32 vs SPXC's 1.38
Best for: sleep-well-at-night
BAC
Bank of America Corporation
The Banking Pick

BAC is the clearest fit if your priority is income & stability and defensive.

  • Dividend streak 12 yrs, beta 0.86, yield 2.3%
  • Beta 0.86, yield 2.3%, current ratio 0.42x
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthTRNS logoTRNS19.2% revenue growth vs BAC's -0.5%
ValueJPM logoJPMLower P/E (14.4x vs 15.3x), PEG 0.81 vs 1.59
Quality / MarginsROP logoROP21.1% margin vs TRNS's 2.0%
Stability / SafetyROP logoROPBeta 0.32 vs SPXC's 1.38
DividendsJPM logoJPM1.9% yield, 15-year raise streak, vs BAC's 2.3%, (2 stocks pay no dividend)
Momentum (1Y)SPXC logoSPXC+44.9% vs ROP's -40.8%
Efficiency (ROA)SPXC logoSPXC7.1% ROA vs BAC's 0.9%, ROIC 13.4% vs 3.5%

TRNS vs SPXC vs JPM vs ROP vs BAC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

TRNSTranscat, Inc.
FY 2025
Service
65.4%$217M
Distribution Service
34.6%$115M
SPXCSPX Technologies, Inc.
FY 2023
HVAC Reportable Segment
64.5%$1.1B
Detection and Measurement Reportable Segment
35.5%$619M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
ROPRoper Technologies, Inc.
FY 2025
Software And Related Services
100.0%$12.3B
BACBank of America Corporation
FY 2024
Loans and Leases
32.2%$62.0B
other interest income
14.7%$28.3B
Debt securities
13.5%$26.0B
Federal funds sold and securities borrowed or purchased under agreements to resell
10.3%$19.9B
Investment And Brokerage Services
9.2%$17.8B
Market making and similar activities
6.7%$13.0B
Trading account assets
5.4%$10.4B
Other (4)
7.8%$15.1B

TRNS vs SPXC vs JPM vs ROP vs BAC — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLSPXCLAGGINGJPM

Income & Cash Flow (Last 12 Months)

ROP leads this category, winning 4 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 842.9x TRNS's $333M. ROP is the more profitable business, keeping 21.1% of every revenue dollar as net income compared to TRNS's 2.0%. On growth, SPXC holds the edge at +17.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricTRNS logoTRNSTranscat, Inc.SPXC logoSPXCSPX Technologies,…JPM logoJPMJPMorgan Chase & …ROP logoROPRoper Technologie…BAC logoBACBank of America C…
RevenueTrailing 12 months$333M$2.3B$280.3B$8.1B$191.6B
EBITDAEarnings before interest/tax$40M$492M$81.4B$3.2B$40.0B
Net IncomeAfter-tax profit$7M$254M$57.0B$1.7B$30.5B
Free Cash FlowCash after capex$20M$385M$100.9B$2.6B$12.6B
Gross MarginGross profit ÷ Revenue+32.6%+37.7%+60.0%+69.4%+56.1%
Operating MarginEBIT ÷ Revenue+4.1%+16.9%+25.9%+28.1%+19.7%
Net MarginNet income ÷ Revenue+2.0%+10.8%+20.4%+21.1%+15.9%
FCF MarginFCF ÷ Revenue+5.9%+16.4%+36.0%+31.4%+6.6%
Rev. Growth (YoY)Latest quarter vs prior year+15.8%+17.4%+11.3%
EPS Growth (YoY)Latest quarter vs prior year-56.3%+8.2%+16.0%+59.1%+18.3%
ROP leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

BAC leads this category, winning 5 of 7 comparable metrics.

At 14.7x trailing earnings, BAC trades at a 91% valuation discount to TRNS's 160.1x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs ROP's 2.46x — a lower PEG means you pay less per unit of expected earnings growth.

MetricTRNS logoTRNSTranscat, Inc.SPXC logoSPXCSPX Technologies,…JPM logoJPMJPMorgan Chase & …ROP logoROPRoper Technologie…BAC logoBACBank of America C…
Market CapShares × price$852M$11.5B$896.0B$34.5B$422.8B
Enterprise ValueMkt cap + debt − cash$976M$11.7B$1.50T$43.5B$556.8B
Trailing P/EPrice ÷ TTM EPS160.11x45.46x16.00x23.59x14.66x
Forward P/EPrice ÷ next-FY EPS est.51.85x28.68x14.40x15.29x12.56x
PEG RatioP/E ÷ EPS growth rate2.39x0.90x2.46x0.95x
EV / EBITDAEnterprise value multiple24.76x23.18x18.36x13.99x13.92x
Price / SalesMarket cap ÷ Revenue2.57x5.10x3.20x4.36x2.21x
Price / BookPrice ÷ Book value/share2.83x4.99x2.47x1.82x1.39x
Price / FCFMarket cap ÷ FCF43.60x47.86x8.88x13.83x33.52x
BAC leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

SPXC leads this category, winning 5 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $2 for TRNS. SPXC carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), BAC scores 7/9 vs JPM's 5/9, reflecting strong financial health.

MetricTRNS logoTRNSTranscat, Inc.SPXC logoSPXCSPX Technologies,…JPM logoJPMJPMorgan Chase & …ROP logoROPRoper Technologie…BAC logoBACBank of America C…
ROE (TTM)Return on equity+2.2%+12.4%+15.9%+8.8%+10.1%
ROA (TTM)Return on assets+1.4%+7.1%+1.3%+5.0%+0.9%
ROICReturn on invested capital+2.6%+13.4%+4.5%+6.1%+3.5%
ROCEReturn on capital employed+3.3%+14.0%+8.9%+7.7%+4.5%
Piotroski ScoreFundamental quality 0–955567
Debt / EquityFinancial leverage0.43x0.22x2.60x0.47x1.21x
Net DebtTotal debt minus cash$124M$134M$599.0B$9.0B$134.1B
Cash & Equiv.Liquid assets$5M$364M$343.3B$297M$231.8B
Total DebtShort + long-term debt$129M$498M$942.4B$9.3B$365.9B
Interest CoverageEBIT ÷ Interest expense2.81x10.50x0.74x6.50x0.48x
SPXC leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

SPXC leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in SPXC five years ago would be worth $38,893 today (with dividends reinvested), compared to $7,526 for ROP. Over the past 12 months, SPXC leads with a +44.9% total return vs ROP's -40.8%. The 3-year compound annual growth rate (CAGR) favors SPXC at 39.9% vs ROP's -8.8% — a key indicator of consistent wealth creation.

MetricTRNS logoTRNSTranscat, Inc.SPXC logoSPXCSPX Technologies,…JPM logoJPMJPMorgan Chase & …ROP logoROPRoper Technologie…BAC logoBACBank of America C…
YTD ReturnYear-to-date+59.7%+13.2%-0.5%-22.5%+1.1%
1-Year ReturnPast 12 months+17.9%+44.9%+21.8%-40.8%+28.1%
3-Year ReturnCumulative with dividends-1.0%+173.6%+138.2%-24.1%+103.0%
5-Year ReturnCumulative with dividends+66.3%+288.9%+118.2%-24.7%+47.1%
10-Year ReturnCumulative with dividends+769.1%+1434.7%+465.8%+112.0%+368.2%
CAGR (3Y)Annualised 3-year return-0.3%+39.9%+33.6%-8.8%+26.6%
SPXC leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ROP and BAC each lead in 1 of 2 comparable metrics.

ROP is the less volatile stock with a 0.32 beta — it tends to amplify market swings less than SPXC's 1.38 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BAC currently trades 97.3% from its 52-week high vs ROP's 58.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTRNS logoTRNSTranscat, Inc.SPXC logoSPXCSPX Technologies,…JPM logoJPMJPMorgan Chase & …ROP logoROPRoper Technologie…BAC logoBACBank of America C…
Beta (5Y)Sensitivity to S&P 5001.35x1.38x0.94x0.32x0.86x
52-Week HighHighest price in past year$94.76$246.68$337.25$575.77$57.55
52-Week LowLowest price in past year$50.23$152.79$262.71$305.96$43.66
% of 52W HighCurrent price vs 52-week peak+96.3%+93.3%+95.1%+58.2%+97.3%
RSI (14)Momentum oscillator 0–10062.761.859.148.568.3
Avg Volume (50D)Average daily shares traded155K561K7.0M1.1M31.7M
Evenly matched — ROP and BAC each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.

Analyst consensus: TRNS as "Buy", SPXC as "Buy", JPM as "Buy", ROP as "Buy", BAC as "Buy". Consensus price targets imply 36.6% upside for ROP (target: $458) vs 5.9% for JPM (target: $340). For income investors, BAC offers the higher dividend yield at 2.26% vs ROP's 0.98%.

MetricTRNS logoTRNSTranscat, Inc.SPXC logoSPXCSPX Technologies,…JPM logoJPMJPMorgan Chase & …ROP logoROPRoper Technologie…BAC logoBACBank of America C…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$123.60$252.00$339.75$457.64$61.13
# AnalystsCovering analysts1012612354
Dividend YieldAnnual dividend ÷ price+1.9%+1.0%+2.3%
Dividend StreakConsecutive years of raises00151212
Dividend / ShareAnnual DPS$5.95$3.29$1.27
Buyback YieldShare repurchases ÷ mkt cap+0.1%0.0%+3.9%+1.5%+5.1%
Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.
Key Takeaway

SPXC leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). ROP leads in 1 (Income & Cash Flow). 2 tied.

Best OverallSPX Technologies, Inc. (SPXC)Leads 2 of 6 categories
Loading custom metrics...

TRNS vs SPXC vs JPM vs ROP vs BAC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is TRNS or SPXC or JPM or ROP or BAC a better buy right now?

For growth investors, Transcat, Inc.

(TRNS) is the stronger pick with 19. 2% revenue growth year-over-year, versus -0. 5% for Bank of America Corporation (BAC). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate Transcat, Inc. (TRNS) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — TRNS or SPXC or JPM or ROP or BAC?

On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.

7x versus Transcat, Inc. at 160. 1x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Roper Technologies, Inc. 's 1. 59x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — TRNS or SPXC or JPM or ROP or BAC?

Over the past 5 years, SPX Technologies, Inc.

(SPXC) delivered a total return of +288. 9%, compared to -24. 7% for Roper Technologies, Inc. (ROP). Over 10 years, the gap is even starker: SPXC returned +1435% versus ROP's +112. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — TRNS or SPXC or JPM or ROP or BAC?

By beta (market sensitivity over 5 years), Roper Technologies, Inc.

(ROP) is the lower-risk stock at 0. 32β versus SPX Technologies, Inc. 's 1. 38β — meaning SPXC is approximately 332% more volatile than ROP relative to the S&P 500. On balance sheet safety, SPX Technologies, Inc. (SPXC) carries a lower debt/equity ratio of 22% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — TRNS or SPXC or JPM or ROP or BAC?

By revenue growth (latest reported year), Transcat, Inc.

(TRNS) is pulling ahead at 19. 2% versus -0. 5% for Bank of America Corporation (BAC). On earnings-per-share growth, the picture is similar: Bank of America Corporation grew EPS 18. 6% year-over-year, compared to -63. 7% for Transcat, Inc.. Over a 3-year CAGR, SPXC leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — TRNS or SPXC or JPM or ROP or BAC?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus 1. 6% for Transcat, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ROP leads at 28. 3% versus 4. 0% for TRNS. At the gross margin level — before operating expenses — ROP leads at 69. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is TRNS or SPXC or JPM or ROP or BAC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Roper Technologies, Inc. 's 1. 59x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 6x forward P/E versus 51. 9x for Transcat, Inc. — 39. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ROP: 36. 6% to $457. 64.

08

Which pays a better dividend — TRNS or SPXC or JPM or ROP or BAC?

In this comparison, BAC (2.

3% yield), JPM (1. 9% yield), ROP (1. 0% yield) pay a dividend. TRNS, SPXC do not pay a meaningful dividend and should not be held primarily for income.

09

Is TRNS or SPXC or JPM or ROP or BAC better for a retirement portfolio?

For long-horizon retirement investors, Roper Technologies, Inc.

(ROP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 32), 1. 0% yield, +112. 0% 10Y return). Both have compounded well over 10 years (ROP: +112. 0%, TRNS: +769. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between TRNS and SPXC and JPM and ROP and BAC?

These companies operate in different sectors (TRNS (Industrials) and SPXC (Industrials) and JPM (Financial Services) and ROP (Industrials) and BAC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: TRNS is a small-cap high-growth stock; SPXC is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock; ROP is a mid-cap quality compounder stock; BAC is a large-cap deep-value stock. JPM, ROP, BAC pay a dividend while TRNS, SPXC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.